Rotating placement sites may help reduce irritation
Plus, while our bodies can produce some antioxidant compounds, production of those antioxidants naturally declines with age
Drugs aimed at mTOR (everolimus, metformin), AKT (MK2206), PI3K (buparlisib, rigosertib) are undergoing phase1-3 clinical trials in advanced pancreatic cancer patients (Wolpin et al., 2009
Ozempic (semaglutide) and Mounjaro (tirzepatide) are approved for diabetes but also prescribed for weight loss off-label quite often
For Immune Support : 1 injection weekly during cold and flu season, or monthly for year-round protection
Food and Drug Administration (FDA) in 2005 for the treatment of type 2 diabetes